Androgenetic alopecia; drug safety and therapeutic strategies

    January 2018 in “Expert Opinion on Drug Safety
    Image of study
    TLDR Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.
    This document from 5 years ago discusses drug safety and therapeutic strategies for treating androgenetic alopecia (AGA), a type of hair loss caused by genetics and hormones. The paper recommends a personalized approach to treatment using 5a-reductase inhibitors, topical minoxidil, and low-level laser therapy. The authors propose revisiting the use of finasteride, which only partially suppresses dihydrotestosterone and has predictable adverse effects. The article also highlights the negative impact of AGA on patients' quality of life, causing stress, low self-esteem, reduced satisfaction with body image, depression, and anxiety.
    View this study on →

    Cited in this study